Deerland Probiotics & Enzymes Hires Vice President of Sales-Americas, Expands Executive Team

KENNESAW, GA (November 18, 2020) – Deerland Probiotics and Enzymes has announced the hiring of a new vice president of sales-Americas as well as the creation of a new executive level position for product development and supply chain.

Michelle Cook has been named the company’s vice president of sales for the Americas region. Cook brings more than 25 years of experience leading sales teams in the OTC pharmaceutical and dietary supplement industries, most recently with DuPont Nutrition & Biosciences. She will oversee Deerland’s team of business development managers as they serve customers across the dietary supplement, food and beverage and pet nutrition industries.

With the addition of Michelle Cook as vice president of sales, Tod Burgess, who previously held the position for more than 20 years, has moved into the newly created role of vice president of product development and supply chain.  In this role, Burgess’s expertise will be harnessed to optimize the up-front product development process and supply chain continuity.

Scott Ravech, CEO, comments, “The addition of Michelle Cook to our staff along with Tod’s new role as vice president of product development and supply chain position demonstrates Deerland’s commitment to placing the best people in critical roles in order to provide maximum value for our customers.”

Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in developing science-backed solutions that benefit microbiome health, using probiotic, prebiotic and enzyme technology.  The company offers a line of unique, clinically validated branded products, including DE111®, PreforPro®, ProHydrolase®, Solarplast®, Glutalytic® and Bifolac® probiotic strains.  Deerland collaborates with customers to develop innovative and often proprietary solutions in the dietary supplement, food and beverage, sports nutrition, and companion animal markets. In addition to branded ingredients and customized formulations, Deerland offers full turnkey products for private label through its YourBrand® portfolio.  The company’s manufacturing services include bulk blends, capsules, stick packs and tablets, as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or visit www.deerland.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More